Fraunhofer Institute for Toxicology and Experimental Medicine

Fraunhofer Research consortium iCAIR® makes use of synergies to develop new medications against SARS-CoV-2.

Non-invasive ventilation system based on 3D-printable components for COVID-19 patients will be further developed.

Despite short-term authorization of certain disinfectants by way of exception, safety and efficacy are top priority.

Fraunhofer ITEM scientists contribute their expertise to the professional program M.Sc. Sustainable Chemistry at Leuphana University Lüneburg.

Fraunhofer ITEM is investigating the mechanisms of metastasis formation.

The EN ISO 13485 certificate for contract design and development of medical inhalation systems and implants is opening up new avenues in our Division of Translational Biomedical Engineering.

Research at Fraunhofer ITEM is focused on human health – and this has been so for almost four decades.

The emphasis is on two aspects: firstly, on protecting health from potentially harmful, in particular airborne substances, be they gases, aerosols, particles, fibers, or nanomaterials, and secondly, on investigating and developing diagnostic and therapeutic approaches, both at the preclinical and clinical levels.

A special focus is on airway research.